Clinical Trials List
2025-01-01 - 2028-12-31
Others
Not yet recruiting2
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Trial Applicant
A2 HEALTHCARE TAIWAN CORPORATION
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 柯凱雄 Division of Radiology
- 陳盈潔 Division of Thoracic Medicine
- 鄭立廷 Division of Thoracic Medicine
- 簡志峯 Division of Thoracic Medicine
- 吳世偉 Division of Thoracic Medicine
- 張山岳 Division of Thoracic Medicine
- 葉人華 Division of Hematology & Oncology
- 賴學緯 Division of Hematology & Oncology
- 吳俊漢 Division of Thoracic Medicine
- 陳明琮 Division of Thoracic Medicine
- 劉佳鑫 Division of Thoracic Medicine
- 簡志峰 Division of Thoracic Medicine
- 沈志浩 Division of Thoracic Medicine
- 陳昱光 Division of Hematology & Oncology
- 蔡文銓 Division of Others
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Jih-Hsiang Lee Division of Hematology & Oncology
- 許嘉林 Division of General Internal Medicine
- 楊景堯 Division of General Internal Medicine
- 錢穎群 Division of General Internal Medicine
- CHAO-CHI HO CHAO-CHI HO Division of General Internal Medicine
- YEN-TING LIN Division of General Internal Medicine
- 陳冠宇 Division of General Internal Medicine
- 廖唯昱 Division of General Internal Medicine
- Chong-Jen Yu Division of General Internal Medicine
- Chia-Chi Lin Division of Hematology & Oncology
- 黃俊凱 Division of General Internal Medicine
- 廖斌志 Division of Hematology & Oncology
- 吳尚俊 Division of General Internal Medicine
- 徐偉勛 醫學研究部
- James Chih-Hsin Yang Division of Hematology & Oncology
- 蔡子修 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
4 participants
-
Global
176 participants